[go: up one dir, main page]

ITMI920405A1 - Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono - Google Patents

Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Info

Publication number
ITMI920405A1
ITMI920405A1 IT000405A ITMI920405A ITMI920405A1 IT MI920405 A1 ITMI920405 A1 IT MI920405A1 IT 000405 A IT000405 A IT 000405A IT MI920405 A ITMI920405 A IT MI920405A IT MI920405 A1 ITMI920405 A1 IT MI920405A1
Authority
IT
Italy
Prior art keywords
heparin
preparation
pharmaceutical compositions
compositions containing
eparan
Prior art date
Application number
IT000405A
Other languages
English (en)
Inventor
Pietro Bianchini
Lino Liverani
Giuseppe Mascellani
Original Assignee
Opocrin Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opocrin Spa filed Critical Opocrin Spa
Priority to ITMI920405A priority Critical patent/IT1254216B/it
Publication of ITMI920405A0 publication Critical patent/ITMI920405A0/it
Priority to ES93102527T priority patent/ES2110015T3/es
Priority to AT93102527T priority patent/ATE161273T1/de
Priority to DE69315724T priority patent/DE69315724D1/de
Priority to EP93102527A priority patent/EP0557887B1/en
Publication of ITMI920405A1 publication Critical patent/ITMI920405A1/it
Application granted granted Critical
Publication of IT1254216B publication Critical patent/IT1254216B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
ITMI920405A 1992-02-25 1992-02-25 Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono IT1254216B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI920405A IT1254216B (it) 1992-02-25 1992-02-25 Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ES93102527T ES2110015T3 (es) 1992-02-25 1993-02-18 Derivados de polisacaridos de heparina, sulfato de heparan, sus fracciones y fragmentos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AT93102527T ATE161273T1 (de) 1992-02-25 1993-02-18 Polysaccharidderivate von heparin, heparansulfate, ihre fraktionen und fragmente, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, welche diese enthalten
DE69315724T DE69315724D1 (de) 1992-02-25 1993-02-18 Polysaccharidderivate von Heparin, Heparansulfate, ihre Fraktionen und Fragmente, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, welche diese enthalten
EP93102527A EP0557887B1 (en) 1992-02-25 1993-02-18 Polysaccharide derivatives of heparin, heparan sulphate, fraction and fragments thereof, process for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920405A IT1254216B (it) 1992-02-25 1992-02-25 Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
ITMI920405A0 ITMI920405A0 (it) 1992-02-25
ITMI920405A1 true ITMI920405A1 (it) 1993-08-25
IT1254216B IT1254216B (it) 1995-09-14

Family

ID=11362117

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920405A IT1254216B (it) 1992-02-25 1992-02-25 Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Country Status (5)

Country Link
EP (1) EP0557887B1 (it)
AT (1) ATE161273T1 (it)
DE (1) DE69315724D1 (it)
ES (1) ES2110015T3 (it)
IT (1) IT1254216B (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688272B2 (en) * 1992-07-24 1998-03-12 Paringenix, Inc. Medicameny for inhibiting neutrophil elastase and cathepsin
US5668118A (en) * 1992-07-24 1997-09-16 Cavalier Pharmaceuticals Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US5583121A (en) * 1994-01-12 1996-12-10 Michigan State University Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US6127347A (en) * 1994-01-12 2000-10-03 Univ Michigan Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US5633233A (en) * 1995-06-07 1997-05-27 Alberta Research Council Modified kojibiosides analogues
US6217863B1 (en) 1995-10-30 2001-04-17 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase I
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
CA2341412A1 (en) 1998-08-27 2000-03-09 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
EP1190364A2 (en) 1999-04-23 2002-03-27 Massachusetts Institute Of Technology System and method for polymer notation
EP1266013B1 (en) 2000-03-08 2014-10-15 Massachusetts Institute Of Technology Heparinase iii and uses thereof
ATE426805T1 (de) 2000-09-12 2009-04-15 Massachusetts Inst Technology Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
AU2000272704A1 (en) * 2000-09-15 2002-03-26 Boehringer Ingelheim International G.M.B.H Use of compounds for the treatment of obesity
EP1328260A2 (en) 2000-10-18 2003-07-23 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
AU2003225724A1 (en) 2002-03-11 2003-09-29 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US9351992B2 (en) 2007-11-02 2016-05-31 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
CN101584705B (zh) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN101584688B (zh) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
BR112012026542A2 (pt) 2010-04-16 2016-07-12 Momenta Pharmaceuticals Inc abordagem seletiva de tecido
CN103096870B (zh) 2010-06-17 2017-04-19 动量制药公司 调节毛发生长的方法和组合物
US9068957B2 (en) 2011-02-21 2015-06-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
SG10201914117QA (en) 2012-05-09 2020-02-27 Cantex Pharmaceuticals Inc Treatment Of Myelosuppression
EP3003324A4 (en) 2013-05-28 2017-01-25 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
EP3258941A4 (en) 2015-02-17 2018-09-26 Cantex Pharmaceuticals, Inc. Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione

Also Published As

Publication number Publication date
EP0557887B1 (en) 1997-12-17
EP0557887A2 (en) 1993-09-01
IT1254216B (it) 1995-09-14
ITMI920405A0 (it) 1992-02-25
ES2110015T3 (es) 1998-02-01
ATE161273T1 (de) 1998-01-15
EP0557887A3 (it) 1994-02-09
DE69315724D1 (de) 1998-01-29

Similar Documents

Publication Publication Date Title
ITMI920405A1 (it) Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
EP0869749A4 (it)
ITMI912296A0 (it) Nuovi pregna 1,4-diene-3,20.dione-16,17-acetal-21-esteri, procedimento per la loro preparazione, composizione e metodi per il trattamento di stati infiammatori
YU43694A (sh) Magnezijum omeprazol i postupak za dobijanje ovog jedinjenja
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
IT8903328A0 (it) Nuovi derivati eparinici e procedimento per la loro preparazione
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
EP0455582A3 (en) Water-settable compositions, their use and process for the production of articles from such compositions
ITPD950101A0 (it) Processo per la preparazione di idrogel ottenuti da derivati chimici dell'acido ialuronico mediante irradiazioni ultraviolette e loro im- piego in campo biomedico sanitario
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
HUT42481A (en) Process for producing bicyclic compounds of double-ionic structure
IT8920169A0 (it) Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
DE69331479D1 (de) Polyethylenglycol-Hirudin-Konjugate, deren Verfahren zur Herstellung und Verwendung für die Heilung von Thrombosen
FR2714063B1 (fr) Procédé de préparation de collagène à partir de cnidaires, et compositions obtenues utilisables en cosmétique.
IT1130973B (it) Processo per la preparazione di derivati di 5,11-di-idro-6h-pirido(2,3-b) (1,4)-benzodiazepin-6-one,derivati finali ed intermedi di sintesi in tal modo ottenuti
ATE118004T1 (de) 4-amidino-chroman und 4-amidino-pyrano(3,2- c)pyridinderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
IT1255471B (it) Derivati di catecolammine,processo per la loro preparazione e composizioni farmaceutiche che li contengono
IT8921513A0 (it) Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmacuetiche che li contengono.
IT8922275A0 (it) Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
CA2160440A1 (en) Method of Manufacturing Non-Absorbable Synthetic Sulfated Polysaccharides
DE59006494D1 (de) Polysaccharide mit antiphlogistischer Wirkung, Verfahren zu ihrer Gewinnung und sie enthaltende Arzneimittel.
IT1276321B1 (it) Derivati del carbossimetilidenecicloptimmidazolo procedimento di fabbricazione dei derivati e agenti terapeutici che contengono
IT1237783B (it) Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.
ITMI972622A1 (it) Derivati del 2-fenilazulene e metodo per la produzione di questi composti
ATE138939T1 (de) Niedermolekulare sulfatierte poly--g(b)-2,6- fructofuranosane und deren verwendung zur behandlung von degenerativen gelenkerkrankungen